Clay Siegall: American Innovator
Why is it that many of the most intellectually talented individuals on the planet never seem to get the credit they deserve? People that do things to better man-kind always seem to get overshadowed by some entertainer or professional athlete. Have you ever heard of a guy named Clay Siegall? More than likely you haven’t, but this guy is a pioneer in cancer research and has been for many years. Clay Siegall is a well known and accomplished guy that is well respected in the industry. He’s President and CEO of one of the top Biotech companies in the world that specializes in cancer research. With a (BS) in Zoology and PH.D in Genetics, Siegall has an extensive educational background that spans for decades back.
Since it’s inception in the late 90’s, Seattle Genetics has grown dramatically over the years. It has become a powerhouse thanks to it’s many progressive fighting cancer drugs. ADCETRIS, which is one of the best antibody drug conjugates, was developed here at Seattle Genetics and it has now gone worldwide in over 65 countries. Of course this is all by the hands of Clay Siegall as he has entered the drug into multiple strategic licensing deals with prominent organizations such as GlaxoSmithKline, AbbVie, Pfizer, and Genentech. ADCETRIS has racked up the profits as well at around $325 Million to this very day. Forbes Magazine ranked the organization as one of the fastest growing companies in the U.S. over the past two years. Clay Siegall’s strong belief in scientific innovation, rigorous research, and drug development has built a sturdy foundation to stand on and it’s producing great results.
Clay Siegall has racked up many awards as well in this industry. He’s won the 2013 Alumnus Of The Year Award for Math, Computer, and Science. He’s also won the 2012 Pacific Northwest Ernst & Young Entrepreneur of The Year Award also. Thanks to Clay Siegall and Seattle Genetics, lives are being saved on a daily basis and that has to stand for something.